NDC 0378-3121

NDC 0378-3121

NDC 0378-3121 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 0378-3121
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 0378-3121-01 [00378312101]

Repaglinide TABLET
Marketing CategoryANDA
Application NumberANDA090252
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-08-27
Marketing End Date2018-12-31

NDC 0378-3121-05 [00378312105]

Repaglinide TABLET
Marketing CategoryANDA
Application NumberANDA090252
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-08-27
Marketing End Date2018-12-31

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.